Cargando…
Atezolizumab-induced psoriasis in a patient with metastatic lung cancer—a case report
Immune checkpoint inhibitors, now FDA-approved, are being increasingly used for diverse cancer types. Dermatological complications are most frequent immune-related adverse events during immune checkpoints inhibitors therapies. There is no case reporting psoriasis exacerbation from Asia until now. We...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798521/ https://www.ncbi.nlm.nih.gov/pubmed/35117743 http://dx.doi.org/10.21037/tcr.2020.03.57 |